$0.747
-0.440 (-58.96%)At close
DHAI News
DHAI Events
DIH Holding declares reverse stock split for Series A common shares
DIH Holding announced that it will implement a reverse stock split of its Class A Common Stock, par value $0.0001 per share, at a ratio of 1-for-25. The Reverse Stock Split was approved by the Company's stockholders at the Company's Special Meeting of Stockholders held on September 25, 2025, with the final ratio subsequently determined by the Company's Board of Directors on September 26, 2025. The Reverse Stock Split will take effect at market open on October 20, 2025, and the Common Stock will trade on a post-split basis on the Nasdaq Stock Market under the Company's existing trading symbol "DHAI." The new CUSIP number following the Reverse Stock Split will be 23290B205.
DIH Holding Issued Another Noncompliance Notice by Nasdaq
DIH Holding received a notice from the Nasdaq that it had failed to regain compliance under Nasdaq Listing Rule 5450 and, accordingly, the staff notified the company that this matter would serve as an additional basis for delisting.
DIH Holding Gets Nasdaq Delisting Notice, Plans to Appeal
DIH Holding received a notice from Nasdaq that it had failed to regain compliance for continued listing requirements of Nasdaq. The company did not regain compliance with the MVLS Rule by September 1 and, accordingly, by letter dated September 2, the staff notified the company that its securities were subject to delisting from Nasdaq unless the company timely requests a hearing before the Nasdaq Hearing Panel. The company plans to timely request a hearing before the panel which will stay any further action for an initial period of 15 days. In connection with the hearing request, the company plans to also request for an extended stay of any further action pending the hearing.
DIH Holding appoints Burell to its board of directors
DIH Holding US announced the appointment of Scott Burell to its Board of Directors. The Board of Directors now comprises six members, with four independent members.
DIH Holding appoints Nick Ward to Scientific Advisory Board
DIH Holding US announced the appointment of Professor Nick Ward, M.D. to its Scientific Advisory Board. Nick Ward, M.D., is a Professor of Clinical Neurology and Neurorehabilitation at the Institute of Neurology at University College London and at the National Hospital for Neurology and Neurosurgery in London, UK.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.